Literature DB >> 730392

[Tobramycin Concentration in Human Lung Tissue (author's transl)].

U Kroening, S Liebig, M Wundschock.   

Abstract

In 27 patients it was experimentally demonstrated that after an i. m. injection of 80 mg tobramycin concentrations are obtained in human lung tissue which for about two hours are higher than the minimal inhibition concentration of most gramnegative organisms. In 14 samples of the latissimus dorsi muscle no detectable tobramycin concentrations were found up two hours after injection of the same dose. The ratio of whole blood concentration and lung tissue concentration is 2 : 1. The measurement of tobramycin concentration in whole blood thus enables the concentration in lung tissue to be estimated. The results show--like all serum and tissue level assays--a high individual variation, which might be dependent on the non-defined factors of binding or metabolism, especially as during the examination period of two hours no concentration balance is accomplished between the two compartments. Administration of 80 mg tobramycin i. m. every six hours is recommended in patients with pulmonary infections due to gramnegative organisms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730392     DOI: 10.1007/bf01642315

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Tobramycin serum levels and tissue content in children.

Authors:  F Daschner
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

2.  [Ethambutol concentrations after oral and intravenous administration (author's transl)].

Authors:  H Jungbluth; R Urbanczik
Journal:  Prax Pneumol       Date:  1974-09

3.  Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.

Authors:  S R Westenfelder; G Welling; P O Madsen
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  Nebramycin, a new broad-spectrum antibiotic complex. I. Detection and biosynthesis.

Authors:  W M Stark; M M Hoehn; N G Knox
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

5.  [Gentamicin concentrations in tissues and body fluids of various animals].

Authors:  H Wahlig; A Metallinos; W Hameister; R Bergmann
Journal:  Int J Clin Pharmacol       Date:  1974-10

6.  Clinical and laboratory studies with tobramycin.

Authors:  A M Geddes; J A Goodall; C F Speirs; A P Gillett; J Andrews; J D Williams
Journal:  Chemotherapy       Date:  1974       Impact factor: 2.544

7.  Tobramycin in bronchial secretions.

Authors:  J E Pennington; H Y Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

  7 in total
  8 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Penetration of cefaclor into bronchial mucosa.

Authors:  G E Marlin; A J Nicholls; G R Funnell; R Bradbury
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

3.  Penetration of piperacillin into bronchial mucosa and sputum.

Authors:  G E Marlin; K R Burgess; J Burgoyne; G R Funnell; M D Guinness
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

4.  Bronchial secretion levels of amikacin.

Authors:  W L Dull; M R Alexander; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Pharmacokinetics and human tissue penetration of flurithromycin.

Authors:  G Benoni; L Cuzzolin; R Leone; U Consolo; G Ferronato; C Bertrand; V Puchetti; M E Fracasso
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 6.  [Tobramycin concentrations in human renal tissue (author's transl)].

Authors:  O Brückner; U Kroening; R Nagel
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.

Authors:  C Muller-Serieys; C Bancal; M C Dombret; P Soler; G Murciano; M Aubier; E Bergogne-Berezin
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

8.  Levels of flurithromycin in female genital tissue.

Authors:  P M Furneri; A Cianci; L Campo; L S Roccasalva; G Tempera; G Fiore; G Palumbo; A M Lepore; G Nicoletti
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.